Solid organ transplants following hematopoietic stem cell transplant in children

Area of Science:

• Pediatric Hematology/Oncology
• Transplantation Medicine
• Immunology

Background:

• Hematopoietic stem cell transplantation (HSCT) is a curative therapy for various pediatric diseases.
• Permanent organ failure can occur post-HSCT, necessitating alternative treatment strategies.
• Solid organ transplantation (SOT) is a potential, yet understudied, option for these complex cases.

Purpose of the Study:

• To evaluate the outcomes of pediatric patients undergoing SOT after HSCT.
• To identify factors influencing SOT success in the post-HSCT population.

Main Methods:

• Retrospective review of eight pediatric patients who received SOT after HSCT at a single center.
• Analysis of patient demographics, underlying HSCT indications, time from HSCT to SOT, SOT type, and patient survival.
• Review of complications and graft function.

Main Results:

• Seven out of eight patients survived with functioning allografts between 6 to 180 months post-SOT.
• Indications for HSCT included genetic disorders, bone marrow failure syndromes, and malignancies.
• Transplanted organs included lungs, kidneys, and liver, with indications such as Bronchiolitis Obliterans, VOD, and chronic GVHD.

Conclusions:

• SOT can be successful in select pediatric patients with organ failure following HSCT.
• Advances in transplantation techniques and supportive care improve outcomes.
• Donor organ availability remains a significant challenge, and careful patient selection is crucial for success.